Beta
Etidronate
medication Under reviewA bisphosphonate medication used to treat Paget's disease of bone and prevent heterotopic ossification.
Research summary
Clinical research on etidronate demonstrates mixed but meaningful results depending on the condition. For postmenopausal osteoporosis, long-term studies show etidronate increases vertebral bone mineral content and maintains fracture rate reductions over extended periods. However, a comprehensive Cochrane systematic review found that etidronate probably makes little to no difference in preventing vertebral and non-vertebral fractures for both primary and secondary prevention in postmenopausal women. More recently, a pilot study in patients with Arterial Calcification due to Deficiency of CD73 (ACDC)—a rare genetic disorder—found that etidronate was safe and well-tolerated, and appeared to slow the progression of new vascular calcification in the lower extremities, though it did not reverse existing calcifications.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Etidronate to your stack to report effects
Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Not specified in source
Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
Not specified in source
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Not specified in source
No reports yet
Be the first to report this effect and help the community.
Add Etidronate to your stack to report effects
Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Not specified in source
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Hypertension — elevated blood pressure requiring management
Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Not specified in source
Research (3 studies)
Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Not specified in source
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Not specified in source
Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
Not specified in source
Community updates
No updates yet for this supplement.
Be the first to share your experience!